Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001193125-12-067426
Filing Date
2012-02-17
Accepted
2012-02-17 16:07:14
Documents
13
Period of Report
2011-12-31

Document Format Files

Seq Description Document Type Size
1 FORM 10-K d285235d10k.htm 10-K 1345526
2 CHANGE IN CONTROL AGREEMENT d285235dex1025.htm EX-10.25 76200
3 SUBSIDIARIES OF DARA BIOSCIENCES, INC. d285235dex21.htm EX-21 3187
4 CONSENT OF ERNST & YOUNG LLP d285235dex23.htm EX-23 4112
5 CERTIFICATION PURSUANT TO SECTION 302 d285235dex311.htm EX-31.1 6106
6 CERTIFICATION PURSUANT TO SECTION 302 d285235dex312.htm EX-31.2 6064
7 CERTIFICATION PURSUANT TO 18 U.S.C. SECTION 1350 d285235dex32.htm EX-32 5287
  Complete submission text file 0001193125-12-067426.txt   4357039

Data Files

Seq Description Document Type Size
8 XBRL INSTANCE DOCUMENT dara-20111231.xml EX-101.INS 559764
9 XBRL TAXONOMY EXTENSION SCHEMA dara-20111231.xsd EX-101.SCH 23163
10 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE dara-20111231_cal.xml EX-101.CAL 46375
11 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE dara-20111231_def.xml EX-101.DEF 28640
12 XBRL TAXONOMY EXTENSION LABEL LINKBASE dara-20111231_lab.xml EX-101.LAB 198920
13 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE dara-20111231_pre.xml EX-101.PRE 129632
Mailing Address 8601 SIX FORKS ROAD SUITE 160 RALEIGH NC 27615
Business Address 8601 SIX FORKS ROAD SUITE 160 RALEIGH NC 27615 919-861-0202
DARA BioSciences, Inc. (Filer) CIK: 0000919745 (see all company filings)

EIN.: 043216862 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 000-23776 | Film No.: 12622753
SIC: 2834 Pharmaceutical Preparations